Preclinical models have indicated that β-arrestin2 (βarr2) knockout mitigates constipation and respiratory depression induced by morphine21, pointing to the possibility that mu opioid receptor (MOR) agonists that preferentially activate G protein signaling over βarr2 recruitment could induce less of these side effects12–14. The gene discussed is OPRM1; the disease is constipation disorder.